PAA 4.88% 19.5¢ pharmaust limited

Ann: MND Trial Completes Enrolment of Cohort 2, page-74

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 129 Posts.
    lightbulb Created with Sketch. 39
    Thanks Paralogical, great visual representation of all trials, are these all current trials globally?
    I notice no one trial shows green in phase 1, could MPL show green in phase 1, interesting to see that not many make it to phase 3 in the green
    I think the deaggregation section we are is ultimately targeting the reduction of the primary cause for MND?

    Thanks
    Bunyip
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.